MAP3K6

mitogen-activated protein kinase kinase kinase 6, the group of Mitogen-activated protein kinase kinase kinases

Basic information

Region (hg38): 1:27355184-27366961

Links

ENSG00000142733NCBI:9064OMIM:604468HGNC:6858Uniprot:O95382AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • gastric cancer (Limited), mode of inheritance: Unknown
  • hereditary diffuse gastric adenocarcinoma (Supportive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Familial gastric cancerADOncologicAwareness of the risk of diffuse gastric cancer may allow preventive measures and early diagnosis and treatmentOncologic25340522

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MAP3K6 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAP3K6 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
8
clinvar
3
clinvar
11
missense
83
clinvar
6
clinvar
10
clinvar
99
nonsense
0
start loss
0
frameshift
1
clinvar
1
clinvar
2
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
1
non coding
1
clinvar
2
clinvar
3
Total 0 1 84 16 16

Variants in MAP3K6

This is a list of pathogenic ClinVar variants found in the MAP3K6 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-27355401-G-C not specified Uncertain significance (Apr 07, 2022)3123008
1-27355435-A-T not specified Uncertain significance (Aug 28, 2024)3542894
1-27355452-C-T not specified Uncertain significance (Jul 02, 2024)3542887
1-27355675-C-T not specified Uncertain significance (Mar 14, 2023)2470582
1-27355675-CG-C Uncertain significance (Nov 01, 2023)493031
1-27355678-G-A not specified Uncertain significance (Oct 29, 2021)2257858
1-27355706-A-C not specified Uncertain significance (Dec 11, 2023)3123007
1-27355710-G-A MAP3K6-related disorder Benign (Dec 31, 2019)782369
1-27356019-G-A MAP3K6-related disorder Likely benign (Nov 12, 2019)3353490
1-27356039-C-G MAP3K6-related disorder Benign (Apr 24, 2019)3055994
1-27356046-C-G not specified Uncertain significance (Sep 14, 2022)2409225
1-27356082-G-C not specified Uncertain significance (Sep 14, 2021)2355463
1-27356402-G-A not specified Uncertain significance (Oct 05, 2023)3123005
1-27356436-G-C not specified Uncertain significance (Nov 15, 2023)3123004
1-27356471-C-T not specified Uncertain significance (May 05, 2023)2568660
1-27356495-C-T MAP3K6-related disorder Likely benign (Mar 01, 2024)3057500
1-27356496-G-A not specified Uncertain significance (Sep 04, 2024)3542897
1-27356633-G-A not specified Uncertain significance (Mar 08, 2024)3123003
1-27356689-T-C Benign (Apr 10, 2018)791784
1-27356725-G-A not specified Likely benign (Mar 19, 2024)3293079
1-27356738-CCTT-C MAP3K6-related disorder Benign (Nov 01, 2024)2638557
1-27357019-C-A Likely benign (Apr 10, 2018)742512
1-27357088-C-G not specified Uncertain significance (Jul 14, 2021)2237636
1-27357124-G-A MAP3K6-related disorder Benign (Dec 23, 2019)3037546
1-27357468-C-T not specified Uncertain significance (Oct 29, 2024)3542888

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MAP3K6protein_codingprotein_codingENST00000493901 2911709
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.05e-160.998124657410871257480.00435
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.246517460.8720.00004788159
Missense in Polyphen189237.010.797432589
Synonymous1.992713160.8570.00001962765
Loss of Function3.053661.90.5810.00000299705

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.005430.00539
Ashkenazi Jewish0.002820.00268
East Asian0.001320.00131
Finnish0.01040.0102
European (Non-Finnish)0.005060.00485
Middle Eastern0.001320.00131
South Asian0.002660.00255
Other0.004210.00408

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways. {ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:9875215}.;
Pathway
MAPK signaling pathway - Homo sapiens (human);EGF-Core;MAPK Signaling Pathway;Angiopoietin Like Protein 8 Regulatory Pathway;Insulin Signaling;p38 MAPK signaling pathway (Consensus)

Recessive Scores

pRec
0.108

Intolerance Scores

loftool
0.849
rvis_EVS
0.37
rvis_percentile_EVS
74.78

Haploinsufficiency Scores

pHI
0.146
hipred
Y
hipred_score
0.533
ghis
0.510

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.976

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Map3k6
Phenotype
neoplasm; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
activation of MAPKK activity;protein phosphorylation;signal transduction;activation of JUN kinase activity
Cellular component
Molecular function
magnesium ion binding;protein kinase activity;MAP kinase kinase kinase activity;ATP binding